SDIs ""The Soldier Modernization Market in China to 2025: Market Brief"" provides a top-level, category specific view of the forecast market value of Soldier Modernization expenditure in China.
SDIs ""The Soldier Modernization Market in China to 2025: Market Brief"", provides a top-level, quantitative view of forecast expenditure of Soldier Modernization sector in China. The information in this brief draws upon SDIs in-depth, primary research and proprietary databases to provide you with robust, category specific data. It is an essential resource for professionals active across the industry value chain and for new players considering entry into the market.
- Market size and forecast statistics for Soldier Modernization expenditure in China to 2025.
- Qualitative analysis of how the market is growing/declining in the forecast period.
Reasons To Buy
- Identify the market trends in China by analyzing the forecast Soldier Modernization expenditure data.
- Use the industry sizing data to understand the current market position and the forecasts to discover where the Soldier Modernization expenditure in China is headed.
1.1 What is this Report About?
1.3 Summary Methodology
1.4 About Strategic Defence Intelligence
2 China Market Size and Forecast 2015-2025
2.1.1 Expenditure on lethality based systems to dominate Chinese soldier modernization expenditure
2.1.2 Chinas expenditure on C4ISR systems to grow at 9.93% over the forecast period
3.2 About SDI
List Of Tables
Table 1: Chinese Soldier Modernization Market Overview
Table 2: Major Chinese Soldier Modernization Programs
Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The companys pipeline products include
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases.
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which
This report provides readers with an exhaustive analysis of industry characteristics, determining the strengths, weaknesses, opportunities and threats faced by the Soldier Modernization market.Key FindingsThis SWOT analysis of Soldier Modernization
USD 600View Report
This report provides readers with a comprehensive analysis of the Soldier Modernization market through 2015-2025, including highlights of the demand drivers and growth stimulators for Soldier Modernization. It also provides
USD 1250View Report
This report provides information on major programs planned in the global Soldier Modernization market. It provides details on top programs in each segment expected to be executed during the forecast
USD 995View Report
PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)
|Published Date||:||Jul 2015|
|No. of Pages||:||14|
|Publisher||:||Strategic Defence Intelligence|
|Report Delivery By||:|
|Report Delivery Time||:||12 to 24 hours after placing the order.|
If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE